OUR MISSION

Founded in 2024, our company specializes in the design, production, and commercialization of affordable real-time PCR tests for detecting nucleotide variants in cancer, microbiology, and natural sciences. We strive to make high-quality diagnostics accessible globally, with a particular focus on low-income regions. Our team of experts, with decades of experience, is dedicated to the principle “Simplicity Matters,” offering flexible, modular tests that are compatible with any PCR instrument. Our proprietary protocols ensure comprehensive mutation coverage, including rare targets, with harmonized workflows and universal process controls, fostering innovation in personalized cancer treatments and modern healthcare.